This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
3 Health-Insurance Stocks to Consider When the Fed Drops Rates
by Mitchell Moore
The next Federal Reserve Open Market Committee meeting is set for July 30-31, where they will decide whether or not to cut interest rates. The market assumes a 100% probability that the Fed cuts rates by at least a quarter point, according to analysts.
UnitedHealth Group (UNH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $246 in the latest trading session, marking a -0.74% move from the prior day.
Molina (MOH) Stock Surges 34% in a Year: More Room to Run
by Zacks Equity Research
Molina's (MOH) restructuring plan should aid revenue growth. This will likely drive its share price further.
The Zacks Analyst Blog Highlights: Amazon, UnitedHealth, AbbVie, Simon Property and Autodesk
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, UnitedHealth, AbbVie, Simon Property and Autodesk
Centene (CNC) Acquires Additional Stake in Ribera Salud
by Zacks Equity Research
Centene (CNC) buys a surplus share in Ribera Salud to fortify its footprint in Europe.
Top Stock Reports for Amazon, UnitedHealth & AbbVie
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), UnitedHealth (UNH) and AbbVie (ABBV).
UnitedHealth's Stock Down in 1H19: What Lies Ahead in 2H?
by Zacks Equity Research
Regulatory disturbances weigh on UnitedHealth's (UNH) stock in the first half of 2019. However, the company is likely to get support from its strong business model.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $242.64, marking a -0.56% move from the previous day.
The Zacks Analyst Blog Highlights: NIKE, Walgreens Boots Alliance, UnitedHealth, Pfizer and Home Depot
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NIKE, Walgreens Boots Alliance, UnitedHealth, Pfizer and Home Depot
Magellan Health Mulls Over Possible Sale to Centerbridge
by Zacks Equity Research
Magellan Health (MGLN) in talks for a possible sale to Centerbridge after its subdued performance.
Dow 30 Stock Roundup: Nike Earnings Disappoint, Walgreens Boots Margins Drop
by Swarup Gupta
The index suffered a disappointing week, declining over three straight trading sessions
UnitedHealth to Buy Equian & Foray into Healthcare Payments
by Zacks Equity Research
UnitedHealth (UNH) is mulling to buy Equian and enter into the expanding healthcare payments space, as per sources.
UnitedHealth (UNH) Closes DaVita Unit Buy, Expands OptumCare
by Zacks Equity Research
UnitedHealth's (UNH) purchase of DaVita Medical Group will likely aid the growth of OptumHealth, which is targeting double-digit percentage revenue long-term growth.
Healthcare Tumbles on Trump's Price Disclosure Order
by Sapna Bagaria
Hospital and health insurers' lose on Trump's executive order to unveil price of services to patients.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $249.64 in the latest trading session, marking a -1.05% move from the prior day.
Stocks March to New Highs on a Dovish Fed Announcement
by David Borun
US Equities add to recent gains as interest rates fall and the Fed signals more cuts ahead
Stock Market News For Jun 20, 2019
by Zacks Equity Research
Wall Street closed higher on Wednesday after the Fed kept the federal fund target rate unchanged.
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $245.80 in the latest trading session, marking a +0.18% move from the prior day.
Why Should UnitedHealth (UNH) Stock Remain in Your Portfolio
by Zacks Equity Research
Banking on a rising top line and health service business, UnitedHealth (UNH) holds great promise to garner benefits for investors.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $245.92 in the latest trading session, marking a -0.89% move from the prior day.
Trade Progress Fuels a Huge Relief Rally
by David Borun
Resolution of the thorny trade issues with Mexico bring about the best week of 2019 for US equities
Dow 30 Stock Roundup: UNH to Hike Dividend, MRK Zerbaxa's New Indication Gets FDA Nod
by Swarup Gupta
The index enjoyed a week of strong gains after the Fed Chair indicated that a near-term rate cut was increasingly likely.
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FTCS
UnitedHealth (UNH) to Offer 20% Hike in Quarterly Dividend
by Zacks Equity Research
United Health's (UNH) shareholders of record on Jun 17, 2019 will receive this meatier dividend on Jun 25, 2019 on the back of the company's solid capital position.